drugset / Trial / NCT01475097

Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography

NCT01475097

Phase 4 Completed 255 enrolled GE Healthcare i3 Statprobe · collab
RandomizedParallel-groupDouble-blind

Summary

The purpose of this study is to evaluate and compare overall patient comfort profile between an Iso-osmolar contrast media (IOCM), iodixanol 320 mg I/mL, and a Low-osmolar contrast media (LOCM), iopamidol 370 mg I/mL in patients undergoing arteriography of peripheral arteries.

Timeline

Start
2011-10
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iodixanol Diagnostic / imaging agent 320 mg/ml Other
Comparator Iopamidol Diagnostic / imaging agent 370 mg/ml Other

Indications

No indication recorded.